Veritas Announces Completion of Clinical Trial on Cannabis Product for Treatment of Acute Pain

Cannabis Business Times
May 15, 2019, 12:32 pm270 ptsTrending
SAN JUAN, Puerto Rico, May 15, 2019 (GLOBE NEWSWIRE) -- PRESS RELEASE -- Veritas Pharma Puerto Rico, Inc., a wholly owned subsidiary of Veritas Pharma Inc. has announced the completion of its clinical trial on its lead cannabis treatment (CTL-X) for acute pain. The clinical trial was designed as a randomized,…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Pending Federal Hemp Legislation Could Reshape The Legal Industry By Banning Some Products (Op-Ed) 80

Up to 24 new cannabis retail permits available in Rhode Island 77

California Passes Bill to Ban Intoxicating Hemp Products Outside Cannabis Market 76

New Mexico cannabis cultivator sues state, alleging toxic flood wrecked crop, company 67

Regulators Ready to Enforce Cannabis Laws on Hemp THC Retailers in Maryland 47

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.